Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Aurora, Colorado

CNS medication trials in Aurora, CO

22 CNS medication studies are recruiting participants at sites in Aurora as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Aurora at a glance

  • 22 studies are recruiting at a site in Aurora.
  • By phase: Phase 1/2 (1), Phase 2 (4), Phase 2/3 (1), Phase 3 (11), Phase 4 (4), No phase (1). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (15), university, hospital or other (6), government (1).
  • By research area: Migraine (6), Parkinson's Disease (6), Depression (4), Epilepsy (3), Multiple Sclerosis (3).
  • Most recent update to one of these records: November 17, 2026.

Depression studies recruiting in Aurora

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Study site
    University of Colorado
    Registry record
    NCT07002034 · updated
  2. Brexanolone Lifting Outcomes Of Moms

    • Phase 3
    • Ages 15 to 45
    • Female participants
    Sponsor
    Lipocine Inc.
    Study site
    Lipocine Investigational Site
    Registry record
    NCT07822321 · updated
  3. NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06963021 · updated
  4. Cannabis for Palliative Care in Cancer

    • Phase 2
    • Ages 25 and older
    • All sexes
    Sponsor
    University of Colorado, Boulder
    Study site
    Anschutz Health Sciences Building
    Registry record
    NCT06266611 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Aurora, CO on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Aurora

  1. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of Colorado Anschutz Medical Campus ( Site 0151)
    Registry record
    NCT06623422 · updated
  2. An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Study site
    University of Colorado Anschutz
    Registry record
    NCT06996652 · updated
  3. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    • Phase 2
    • Ages 40 to 80
    • All sexes
    Sponsor
    Neuron23 Inc.
    Study site
    University of Colorado - Anschutz Medical Campus
    Registry record
    NCT06680830 · updated
  4. A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

    • Phase 2/3
    • Ages 40 to 80
    • All sexes
    Sponsor
    Biohaven Therapeutics Ltd.
    Registry record
    NCT06976268 · updated
  5. A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of Colorado Anschutz Medical Campus ( Site 0061)
    Registry record
    NCT06312176 · updated
  6. Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

    • Phase 4
    • Ages 40 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    Rocky Mountain Regional VA Medical Center, Aurora, CO
    Registry record
    NCT04373317 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Aurora, CO on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Aurora

  1. A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    UC Health Neuroscience Ctr
    Registry record
    NCT07225504 · updated
  2. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

    • Phase 3
    • Ages 18 to 60
    • All sexes
    Sponsor
    Sanofi
    Study site
    Rocky Mountain Regional VA Medical Center- Site Number : 8400121
    Registry record
    NCT07325292 · updated
  3. Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    University of Colorado Anschutz Medical Campus
    Registry record
    NCT06529406 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Aurora, CO on ClinicalTrials.gov.

Epilepsy studies recruiting in Aurora

  1. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    Colorado Children's Hospital
    Registry record
    NCT05419492 · updated
  2. A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

    • Phase 3
    • From 1 day, up to 18 years
    • All sexes
    Sponsor
    Praxis Precision Medicines
    Study site
    Praxis Research Site
    Registry record
    NCT07019922 · updated
  3. Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

    • Phase 4
    • From 12 months, up to 24 months
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    Children's Hospital Colorado
    Registry record
    NCT06598449 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Aurora, CO on ClinicalTrials.gov.

Migraine studies recruiting in Aurora

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    University of Colorado Anschutz Medical Campus
    Registry record
    NCT06972056 · updated
  2. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Paradigm Clinical Research Centers, LLC; Aurora
    Registry record
    NCT07816367 · updated
  3. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Children's Hospital Colorado · Children's Hospital Colorado- lnvestigational Drug Services
    Registry record
    NCT04649242 · updated
  4. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Children's Hospital Colorado · Children's Hospital Colorado- Investigational Drug Services
    Registry record
    NCT04743141 · updated
  5. Responding With Evidence and Access for Childhood Headaches

    • No phase
    • Ages 10 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    University of Colorado/Children's Hospital Colorado
    Registry record
    NCT05889624 · updated
  6. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study sites
    Children's Hospital Colorado - Aurora /ID# 231879 · Paradigm Clinical Research - Aurora, CO /ID# 280612
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Aurora, CO on ClinicalTrials.gov.

Ask about studies near Aurora

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call